AWCI
CLBT icon

Alpine Woods Capital Investors’s Cellebrite CLBT Stock Holding History

Alpine Woods Capital Investors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,207
Closed -$223K – 224
2026
Q1 		$223K Buy
+16,207
New +$244K 0.05% 179

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Alpine Woods Capital Investors's CLBT Position: Q2 2026 in Review

Alpine Woods Capital Investors sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 16,207 shares — an estimated $223K sold.

Alpine Woods Capital Investors first reported a position in CLBT in Q1 2026 and held it in 1 quarter. The position peaked at $223K in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Alpine Woods Capital Investors reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Alpine Woods Capital Investors sold 16,207 Cellebrite shares in Q2 2026, an estimated $223K.
  • Alpine Woods Capital Investors first reported a position in Cellebrite in Q1 2026 and held it in 1 quarter.
  • Alpine Woods Capital Investors's Cellebrite position peaked at $223K in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.